PEPG (PepGen Inc.) Stock Financials & Earnings | Market Cap Arena

PEPG (PepGen Inc.) Stock Financials & Earnings | Market Cap Arena

PEPGPepGen Inc.

Mkt Cap$435M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$94M

EPS (TTM)-$2.82

Free Cash Flow (TTM)-$82M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$0	-$17M
Q1 23	$0	$0	-$18M
Q2 23	$0	$0	-$21M
Q3 23	$0	$0	-$25M
Q4 23	$0	-$354K	-$21M
Q1 24	$0	-$376K	-$20M
Q2 24	$0	$0	-$30M
Q3 24	$0	$0	-$23M
Q4 24	$0	-$380K	-$24M
Q1 25	$0	$0	-$31M
Q2 25	$0	$0	-$24M
Q3 25	$0	-$339K	-$19M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$15M	-$17M
Q2 23	-$18M	-$19M
Q3 23	-$16M	-$17M
Q4 23	-$19M	-$20M
Q1 24	-$23M	-$23M
Q2 24	-$16M	-$16M
Q3 24	-$24M	-$24M
Q4 24	-$19M	-$20M
Q1 25	-$23M	-$23M
Q2 25	-$24M	-$24M
Q3 25	-$19M	-$19M
Q4 25	-$16M	-$16M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$1M
Q2 23	$1M
Q3 23	$225K
Q4 23	$184K
Q1 24	$53K
Q2 24	$31K
Q3 24	$185K
Q4 24	$228K
Q1 25	$125K
Q2 25	$43K
Q3 25	$97K
Q4 25	$1K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	—	+138.7%
Q1 23	—	+29.8%
Q2 23	—	+19.9%
Q3 23	—	+26.7%
Q4 23	—	+20.9%
Q1 24	—	+9.8%
Q2 24	—	+43.9%
Q3 24	—	-6.5%
Q4 24	—	+17.0%
Q1 25	—	+58.2%
Q2 25	—	-21.3%
Q3 25	—	-19.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$1M	—
Q2 23	$0	—
Q3 23	$0	—
Q4 23	$0	—
Q1 24	$2M	—
Q2 24	$3M	—
Q3 24	$3M	—
Q4 24	$0	—
Q1 25	$3M	—
Q2 25	$2M	—
Q3 25	$0	—
Q4 25	$2M	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q4 22	$13M	$4M	—
Q1 23	$14M	$4M	—
Q2 23	$17M	$4M	—
Q3 23	$21M	$4M	—
Q4 23	$16M	—	$5M
Q1 24	$14M	$5M	—
Q2 24	$25M	$5M	—
Q3 24	$18M	$5M	—
Q4 24	$19M	—	$5M
Q1 25	$25M	$6M	—
Q2 25	$18M	$6M	—
Q3 25	$13M	$5M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$165M	$0	$165M
Q2 23	$147M	$0	$147M
Q3 23	$130M	$0	$130M
Q4 23	$81M	$30M	$110M
Q1 24	$134M	$41M	$175M
Q2 24	$66M	$95M	$161M
Q3 24	$42M	$97M	$139M
Q4 24	$49M	$71M	$120M
Q1 25	$44M	$54M	$98M
Q2 25	$35M	$40M	$75M
Q3 25	$143M	$21M	$164M
Q4 25	$61M	$88M	$148M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	24M	+0.6%
Q1 23	24M	+0.2%
Q2 23	24M	+0.1%
Q3 23	24M	+0.0%
Q4 23	24M	+0.0%
Q1 24	29M	+20.4%
Q2 24	32M	+13.3%
Q3 24	33M	+0.3%
Q4 24	33M	+0.1%
Q1 25	33M	+0.2%
Q2 25	33M	+0.2%
Q3 25	33M	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 19	—	—
FY 20	—	—
FY 21	—	—
FY 22	$0	45
FY 23	$0	64
FY 24	$0	81
FY 25	$0	200K